Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: improved technology for radiotherapy of cancer and other diseases

Aug. 10, 1999

Korean researchers synthesize anticancer platinum complexes

Aug. 10, 1999

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

Takeda scientists synthesize and evaluate GnRH antagonists

Aug. 9, 1999

Novel cell adhesion inhibitors in the pipeline at Roche

Aug. 9, 1999

Introgen Therapeutics obtains worldwide rights to mda7 gene from Corixa

Aug. 9, 1999

Fournier returns European rights for tgDCC-E1A to Targeted Genetics

Aug. 9, 1999

ADIR discloses alkaloid derivatives with improved potency and solubility

Aug. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...